12:00 AM
 | 
Jul 24, 2000
 |  BC Week In Review  |  Company News  |  Sales & Marketing

Avax sales and marketing update

AVXT launched in Australia its M-Vax vaccine for Stage III melanoma metastatic to the...

Read the full 58 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >